January 5, 2022
Published: Jan 05, 2022 | By Heather McKenzie
To come up with this list, BioSpace looked at companies that launched between September 2020 and September 2021 with Series A funding. They were then weighted by several different categories and ranked in a cumulative fashion, based on the points awarded for each category. These categories were: finance, collaborations, pipeline, growth potential and innovation.
The NextGen Bio Class of 2022 is a stellar group of companies that are already making an enormous impact on the industry now and will continue into the future. Congratulations to this group!